RecruitingNCT07373470
Pharmacogenetic medication management for depression in community pharmacies
About this title
Read the official source — NCT07373470Interventional studyAges 18+United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
Adults with depressive symptoms who have completed pharmacogenomic testing and meet the participating pharmacy and UPMC/Pitt+Me requirements may be eligible. In this randomized study, a community pharmacist reviews the test results and medications with some participants; others receive usual care, with their results shared at the end of the study. Any treatment decisions remain with participants and their regular care teams. Additional eligibility criteria apply.
- Listed locations
- PittsburghSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 9, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 220
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Other
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07373470
- Official title
Show the full official title
Genotype-guided Comprehensive Medication Management to Improve Depression Outcomes in Pennsylvania
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
